Ledger.Open graph →
SEC Form D · Amendment · filed January 19, 2022

EdenRoc Sciences LLC

Offering
$27.6M
Sold
$27.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BIRMINGHAM, MI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

David Sinclair · Cambridge, MADirectorTodd Dickinson · Cambridge, MADirectorGregory Lucier · Cambridge, MADirectorMathew Easterday · Cambridge, MAExecJ. Taylor Crandall · Cambridge, MADirectorEdward Schulak · Cambridge, MAExecDaniel R. Hetu, Md, Mba · San Diego, CAExecKeith A. Katkin · San Diego, CADirectorWilliam R. Harrington, Md, Mba · San Diego, CADirectorEckard R. Weber, Md · San Diego, CAExecLynne R. Rollins · San Diego, CADirectorBrent R. Ahrens · San Diego, CADirectorEdward I. Weisiger, Jr · Charlotte, NCDirectorJon L. Morris · Charlotte, NCDirectorMichael P. Harrell · Charlotte, NCDirectorPeter W. Lash, Jr · Charlotte, NCExecBeacon GP LLC · Charlotte, NCExecSief Khafagi · BEAVERTON, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗